These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 10453834)
1. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834 [TBL] [Abstract][Full Text] [Related]
2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217 [TBL] [Abstract][Full Text] [Related]
3. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ghi T; Huggon IC; Zosmer N; Nicolaides KH Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199 [TBL] [Abstract][Full Text] [Related]
4. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008 [TBL] [Abstract][Full Text] [Related]
5. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988 [TBL] [Abstract][Full Text] [Related]
6. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects]. Baś-Budecka E; Perenc M; Sieroszewski P Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599 [TBL] [Abstract][Full Text] [Related]
7. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. Galindo A; Comas C; Martínez JM; Gutiérrez-Larraya F; Carrera JM; Puerto B; Borrell A; Mortera C; de la Fuente P J Matern Fetal Neonatal Med; 2003 Mar; 13(3):163-70. PubMed ID: 12820838 [TBL] [Abstract][Full Text] [Related]
8. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412 [TBL] [Abstract][Full Text] [Related]
9. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. Hyett J; Perdu M; Sharland G; Snijders R; Nicolaides KH BMJ; 1999 Jan; 318(7176):81-5. PubMed ID: 9880278 [TBL] [Abstract][Full Text] [Related]
10. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Matias A; Huggon I; Areias JC; Montenegro N; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Nov; 14(5):307-10. PubMed ID: 10623988 [TBL] [Abstract][Full Text] [Related]
11. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874 [TBL] [Abstract][Full Text] [Related]
12. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427 [TBL] [Abstract][Full Text] [Related]
13. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency. Lopes LM; Brizot ML; Lopes MA; Ayello VD; Schultz R; Zugaib M Ultrasound Obstet Gynecol; 2003 Nov; 22(5):470-8. PubMed ID: 14618659 [TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698 [TBL] [Abstract][Full Text] [Related]